Kenneth Nicholas Horne
Directeur Général chez Symic Bio, Inc.
Profil
Kenneth Nicholas Horne is currently the Chief Executive Officer & Director at Symic Bio, Inc., the Chief Executive Officer at Symic Holdings LLC, the Chief Executive Officer & Director at Capacity Bio, Inc., the Chief Executive Officer & Secretary at Typewriter Therapeutics, Inc., the Director at Bay Area Discovery Museum, the Vice President at Tautona Group, and the President of Digestome Therapeutics, Inc. He previously worked as the President, Chief Operating Officer & Director at Teon Therapeutics, Inc. Mr. Horne received his undergraduate and graduate degrees from Stanford University.
Postes actifs de Kenneth Nicholas Horne
Sociétés | Poste | Début |
---|---|---|
Tautona Group
Tautona Group Investment ManagersFinance Tautona Group (Tautona Group) is a venture capital firm founded in 2010 by Duke Rohlen. The firm is headquartered in Menlo Park, California. | Private Equity Investor | 18/03/2011 |
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Directeur Général | - |
Bay Area Discovery Museum
Bay Area Discovery Museum Other Consumer ServicesConsumer Services Bay Area Discovery Museum operates as a preschool. The private company is based in Sausalito, CA and has subsidiaries in the United States. | Directeur/Membre du Conseil | - |
Symic Holdings LLC
Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Directeur Général | - |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Directeur Général | - |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Directeur Général | - |
Anciens postes connus de Kenneth Nicholas Horne
Sociétés | Poste | Fin |
---|---|---|
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | President | - |
Formation de Kenneth Nicholas Horne
Stanford University | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 7 |
---|---|
Tautona Group
Tautona Group Investment ManagersFinance Tautona Group (Tautona Group) is a venture capital firm founded in 2010 by Duke Rohlen. The firm is headquartered in Menlo Park, California. | Finance |
Symic Bio, Inc.
Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA. | Health Technology |
Bay Area Discovery Museum
Bay Area Discovery Museum Other Consumer ServicesConsumer Services Bay Area Discovery Museum operates as a preschool. The private company is based in Sausalito, CA and has subsidiaries in the United States. | Consumer Services |
Symic Holdings LLC
Symic Holdings LLC BiotechnologyHealth Technology Symic Holdings LLC develops new category of therapeutics. The company was founded by John Paderi, Kate Stuart and Alyssa Panitch and is headquartered in Emeryville, CA. | Health Technology |
Teon Therapeutics, Inc.
Teon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Teon Therapeutics, Inc. operates as a pharmaceutical company. It focuses on cancer immunotherapy. The company was founded by Yao Lina, Fan Peidong, Elfaith Elzein, and Liiu Jiwen in March 2018 and is headquartered in Redwood City, CA. | Commercial Services |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |
Capacity Bio, Inc.
Capacity Bio, Inc. BiotechnologyHealth Technology Capacity Bio, Inc. is a biotech company based in an undisclosed location. The American company is focused on developing a first-in-class mitophagy therapeutic platform and an advanced analytical toolkit to characterize mitochondria. The company was founded by Amy Wang, Stan Louie, and Kathy Rodgers, and the CEO is Kenneth Nicholas Horne. | Health Technology |